🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →

IDXX NASDAQ 🇺🇸 US

IDEXX Laboratories, Inc.

Healthcare

Watch

Price Zone: Strong Buy

🔒 Full AI Analysis — Pro

47Score

DipBuster Score™

$545.00 $7.46 (-1.35%) Live price · Source: Yahoo

52-Week Position

$518.55 11% of range $769.98

Beta

1.549

Moderate

Dividend

—

no income

Mkt Cap

N/A

total value

Mkt CapN/A

P/EN/A

DividendNone

Beta1.549

52W High$769.98

52W Low$518.55

DipBuster Brief Key signals at a glance

Zone: Strong Buy

Bullish

Near 52-Week Low — Wide Margin of Safety

At 11% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.

Neutral

Earnings Data Unavailable

P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.

🔓 Sign up free to see 1 more signal →

Valuation

P/E Ratio—

Mkt CapN/A

52W Position11% of range

EV/EBITDA—

Cash Flow

FCF Yield—

FCF / Share

Op. Cash Flow—

Margins

Gross Margin—

Op. Margin—

Net Margin—

Balance Sheet

Cash—

Total Debt—

Net Cash—

Dividend

Yield—

Annual / shNone

Beta1.549

🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.

Charts

Create free account to see financial charts

🕵️ Insiders

📊 Valuation

💰 Dividends

📰 News

🤖 AI Analysis

Recent director dealings and insider transactions at IDEXX Laboratories, Inc. (IDXX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date	Insider	Type	Shares
2026-06-01	Fennell George	SELL	639
2026-06-01	Fennell George	SELL	284
2026-06-01	Fennell George	BUY	639
2026-05-12	Peacock Karen	BUY	234
2026-05-12	Peacock Karen	BUY	525
2026-05-12	Samad Sam	BUY	234
2026-05-12	Samad Sam	BUY	525
2026-05-12	Britt Irene Chang	BUY	234
2026-05-12	Britt Irene Chang	BUY	525
2026-05-12	Vandebroek Sophie V.	BUY	234

Valuation

P/E RatioN/A

Market CapN/A

Beta1.549

Dividend/yrNone

52W High$769.98

52W Low$518.55

52-Week Range

$518.55Now$769.98

11% through annual range

From 52W High−29.2%

From 52W Low+5.1%

📖 Plain English Summary

IDEXX Laboratories, Inc. is at 11% of its 52-week range. Beta 1.549 — significantly more volatile than the market.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…

Loading dividend data…

Latest news for IDXX 🟢 Bullish ⬜ Neutral 🔴 Bearish

🤖

DipBuster AI Analysis — IDXX

Heuristic · balance sheet, insider filings, price data, academic research

IDEXX Laboratories, Inc. — DipBuster Score 47/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒

Full AI Analysis — Pro

Price zones, Graham analysis, insider signals

Upgrade →

Track IDEXX Laboratories, Inc. free

Add IDXX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Create free account → Log in

Sponsored · FCA Regulated Broker

Freetrade

Simple investing app. Free ISA. UK and US stocks. FCA regulated.

Free share when you fund your account

Get Started Free →

Capital at risk. Your investments can go down as well as up. Disclaimer

DipBuster Score™ Breakdown

Value & P/E 0/30

Dip Position 36/25

Momentum & Volume 6/25

Quality & Size 5/10

Insider Activity 0/10

🎯 Dip Buyer Signal

22 /100 · NEUTRAL

dip depth 12/25

oversold rsi 5/25

mean reversion 6/15

insider zone 0/25

capitulation 0/10

Technical signal only. Not financial advice.

Quick Take

🟡

Watch

DipBuster Score: 47/100

📊 Run a full check in the AI analysis tab for a deeper look.

Full AI analysis ↓ · How scores work

Company Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestoc…

Sector Healthcare

Market 🇺🇸 US

CEO Michael Erickson

Staff 11,000 employees

Website idexx.com

Similar Stocks